Fredun Pharma Live Share Price Today, Share Analysis and Chart

Name: Fredun Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Fredun Pharmaceuticals Ltd.
Rating: 2.704041625
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Fredun Pharmaceuticals Ltd. is a Mumbai-headquartered pharmaceutical company engaged in the manufacturing and export of a diverse range of healthcare products. The company maintains a global presence across 52 countries, specializing in generic formu...

2532.75 218.10 (9.42%)

Near 52W High of ₹2620.00

24,781

BSE Volume

BSE 16 Jun, 2026 3:31 PM (IST)

Dividend

Fredun Pharma has an upcoming dividend of ₹0.700 per share due on 23 Jun 2026 See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

65.5 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

No estimates available

Fredun Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Fredun Pharmaceuticals Ltd. worth buying?

37 Votes:

Buy 75.68%

Sell 16.22%

Hold 8.11%

Fredun Pharma Live Share Price Today, Share Analysis and Chart

Fredun Pharmaceuticals Ltd. is a Mumbai-headquartered pharmaceutical company engaged in the manufacturing and export of a diverse range of healthcare products. The company maintains a global presence across 52 countries, specializing in generic formu...

Near 52W High of ₹2620.00

SWOT Analysis

Fredun Pharma Live Price Chart